(MENAFN- EIN Presswire)
Breast Imaging
Top Key Players
Koninklijke Philips N.V., GE Healthcare, Siemens Healthcare, Fujifilm Holdings, Hologic, Dilon Technologies.
Breast imaging illuminates the way to early detection and gives women the confidence to take control of their breast health.” - Exactitude Consultancy
LUTON, BEDFORDSHIRE, UNITED KINGDOM, October 11, 2024 /EINPresswire / -- The key trends influencing this domain's growth in terms of the competitive and geographic landscape are defined in the business intelligence report on the Breast Imaging market . Additionally, the report discusses the obstacles to industry growth and provides information on unexplored prospects that will promote company growth between 2024 and 2032.
Learn how to create a business case and an implementation strategy. Find out more about the Breast Imaging market and how it might benefit your company. Key market players' competitive situations are included in this market, with an emphasis on sales revenue, customer wants, company profiles, import/export scenarios, and business strategies that will assist emerging market segments in making important business decisions. The competitive landscape of the global market, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors, and Porter's Five Forces Analysis are all covered in this study.
The global market of Breast imaging is expected to grow at more than 8.2% CAGR from 2024 to 2032. It is expected to reach above USD 6.76 billion by 2032 from USD 3.6 billion in 2024.
Click Here to Get a FREE sample of this latest research report @: #request-a-sample
Major players in the market include: Koninklijke Philips N.V., GE Healthcare, Siemens Healthcare, Fujifilm Holdings Corporation, Hologic, Dilon Technologies.
Important Features of the Reports:
.Detailed analysis of the Breast Imaging market
.Fluctuating market dynamics of the industry
.Detailed market segmentation
.Historical, current and projected market size in terms of volume and value
.Recent industry trends and developments
.Competitive landscape of the Breast Imaging Market
.Strategies of key players and product offerings
.Potential and niche segments/regions exhibiting promising growth
.A neutral perspective towards Breast Imaging market performance.
Breast Imaging Market: Segmental Analysis
Technology Segment, 2024-2032, (in USD million)
Mammography (FFDM, Digital & 3D Mammography)
Molecular Breast Imaging (MBI)/Molecular Breast-Specific Gamma Imaging (BSGI)
PET-CT
Contrast-Enhanced Spectral Mammography (CESM)
Cone Beam Computed Tomography (CBCT)
Automated Breast Ultrasound (ABUS)
Breast MRI
Breast Thermography
Optical Imaging
Electrical Impedance Imaging (EIT)
End-User Segment, 2024-2032, (in USD million)
Hospitals & Clinics
Specialty Centers
Diagnostic Imaging Centers
Key Market Segmentation:
Exactitude Consultancy provides an analysis of the key trends in each sub-segment of the global Breast Imaging market, along with forecasts at the global, regional, and country-level analysis from 2024 to 2032. Our report has categorized the market based on type, offering, technology, system, and end-use industry. The biggest highlight of the report is to provide companies in the industry with a strategic analysis of the impact of COVID-19. At the same time, this report analyzed the market of the leading 20 countries and introduce the market potential of these countries.
For instance:
In Australia, the government's statewide screening program, Breast Screen Australia, requires free mammograms every two years for women between the ages of 50 and 74. Cancer Australia's "Guidance for the management of early breast cancer - Recommendations and practice points," released in September 2020, addressed breast imaging for early diagnosis in the early stages of breast cancer.
The Dutch National Institute for Public Health and the Environment (RIVM), which runs a breast cancer screening program for women aged 50 to 75, stated in April 2022 that fear of contracting the SARS-CoV-2 virus had caused only 70.4% of women to participate in the program the year before.
The National Mammography Program, which offers free mammograms and diagnostic services for the early identification and treatment of breast cancer, is organized annually in the United States by the non-profit National Breast Cancer Foundation, Inc.
The development of the SU2C Canada Metastatic Breast Cancer Dream Team was announced in August 2019 by the Canadian Cancer Society in collaboration with the Canadian Institutes of Health Research (CIHR) and Stand Up to Cancer Canada (SU2C Canada). In order to conduct nationwide clinical trials and public awareness efforts to prevent and treat metastatic breast cancer, this team was awarded $6 million in financing.
Full Report of the Steel Market @:
Geographically, the detailed analysis of consumption, revenue, market share, and growth rate of the following regions:
.North America (the United States, Canada, and Mexico)
.Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
.Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
.South America (Brazil etc.)
.The Middle East and Africa (North Africa and GCC Countries)
Global Breast Imaging Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyses the potential of the global Breast Imaging industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis, and market entry strategy Analysis, opportunities and forecasts.
Key questions answered in the report:
-What will the market development pace of the Breast Imaging Market?
-What are the key factors driving the Breast Imaging Market?
-Who are the key Companies in the market space?
-What are the market openings, market hazards and market outline of the Breast Imaging Market?
-What are the sales, revenue, and price analysis of the top Companies of the Breast Imaging Market?
-Who are the distributors, traders, and dealers of Breast Imaging Market?
-What are the market opportunities and threats faced by the vendors in the Breast Imaging Market?
-What are deals, income, and value examination by types and utilizations of the Breast Imaging Market?
-What are deals, income, and value examination by areas of enterprises in the Breast Imaging Market?
Reason to Buy:
[1] Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global Breast Imaging Market.
[2] Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.
[3] The key findings and recommendations highlight crucial progressive industry trends in the Breast Imaging Market, thereby allowing players to develop effective long-term strategies in order to garner their market revenue.
[4] Develop/modify business expansion plans by using substantial growth offerings in developed and emerging markets.
[5] Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth to a certain extent.
[6] Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.
Top Trending Reports:
Airway Management Devices Market
The Global airway management devices market is expected to grow at more than 7.6% CAGR from 2020 to 2028. It is expected to reach above USD 4.03 billion by 2028 from a little above USD 2.10 billion in 2019.
Anastomosis Device Market
The global anastomosis device market is expected to grow at more than 6.9% CAGR from 2019 to 2028. It is expected to reach above USD 3.04 billion by 2028 from a little above USD 1.70 billion in 2019.
Early Cancer Detection Market
The Global Early Cancer Detection Market is expected to grow at more than 13.8% CAGR from 2019 to 2028. It is expected to reach above USD 2,650 million by 2028 from a little above USD 909 million in 2019.
Boswellia Market
The Global Boswellia Market is expected to grow at more than 5% CAGR from 2019 to 2028. It is expected to reach above USD 153 million by 2028 from a little above USD 90.5 million in 2019.
Resuscitation Devices Market
The global resuscitation devices market size is expected to grow at 4.70% CAGR from 2019 to 2028. It is expected to reach above USD 9.9 billion by 2028 from USD 6.5 billion in 2019.
Microsurgical Instruments Market
The Global Microsurgical Instruments Market is expected to grow at 5.5% CAGR from 2019 to 2028. It is expected to reach above USD 3.2 billion by 2028 from USD 1.8 billion in 2019.
Surface Disinfectant Market
The Global Surface Disinfectant Market is expected to grow at 8.5% CAGR from 2019 to 2028. It is expected to reach above USD 4.72 million by 2028 from USD 2.31 million in 2019.
Dental Imaging Market
The Global Dental Imaging Market size is expected to grow at more than 9.5% CAGR from 2016 to 2028. It is expected to reach above USD 5.9 billion by 2028 from a little above USD 2 billion in 2016.
Rehabilitation Equipment Market
The global rehabilitation equipment market is expected to grow at 5.20% CAGR from 2019 to 2028. It is expected to reach above USD 19.3 billion by 2028 from USD 12.2 billion in 2019.
Haemeto Oncology Testing Market
The Global Haemeto Oncology Testing Market is expected to grow at more than 18.6% CAGR from 2019 to 2028. It is expected to reach above USD 8.23 billion by 2028 from a little above USD 1.93 billion in 2019.
Irfan T
Exactitude Consultancy
+1 704-266-3234
email us here
Visit us on social media:
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN11102024003118003196ID1108770123